Protagenic Therapeutics, Inc. (PTIXW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
149 Fifth Avenue
New York City, NY 10010
United States of America (the)
Phone
212 994 8200
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1
First IPO Date
April 27, 2021
| Name | Title | Pay | Year Born |
| Alexander Kenneth Arrow | Chief Financial Officer | 0 | 1971 |
| Robert Benjamin Stein | Chief Medical Officer | 0 | 1951 |
| William Nichols Jr. | President | 0 | 1975 |
| Garo H. Armen | Executive Chairman | 0 | 1953 |
Protagenic Therapeutics, Inc. is a biopharmaceutical company in its pre-clinical phase, dedicated to discovering and formulating treatments for neuropsychiatric and mood disorders that are related to stress. Its flagship compound, PT00114, is a laboratory-produced variant of teneurin carboxy-terminal associated peptide, a naturally occurring brain signaling peptide recognized for its capacity to moderate excessive stress reactions. The firm was established in 2016 and maintains its principal office in New York, New York.